Lonafarnib
Tier C — Watch / tradeLonafarnib
Targets:Ftase
Brand:Zokinvy, ZOKINVY
Indications (approved):早衰综合征
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LONA-008 | 157688-46-5 | 2-(1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid |
| LONA-009 | 193276-76-5 | tert-butyl (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxylate |
| LONA-010 | 193276-77-6 | (R)-1-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-(piperidin-4-yl)ethan-1-one |
| LONA-011 | 562883-39-0 | 3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-012 | - | 3-bromo-8-chloro-7-nitro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-013 | - | 3-bromo-8-chloro-9-nitro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-014 | 679842-23-0 | 3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-7-amine |
| LONA-015 | 679842-25-2 | 3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-9-amine |
| LONA-016 | 679842-29-6 | 3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-7-amine |
| LONA-017 | 679842-27-4 | 3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-9-amine |
| LONA-018 | 272107-22-9 | 3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-019 | 141699-59-4Available | tert-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate |
| LONA-020 | 273216-60-7 | tert-butyl (R)-4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidine-1-carboxylate |
| LONA-021 | - | tert-butyl (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxylate acetyl-L-phenylalaninate |
| Code | CAS No. | Intermediate |
|---|---|---|
| LONA-001 | 165740-12-5 | ethyl 4-(3-bromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate |
| LONA-002 | 193276-34-5 | ethyl 4-(3-bromo-8-chloro-9-nitro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate |
| LONA-003 | 193276-44-7 | ethyl 4-(9-amino-3-bromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate |
| LONA-004 | 193276-45-8 | ethyl 4-(9-amino-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate |
| LONA-005 | 193276-46-9 | ethyl 4-(3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate |
| LONA-006 | 193276-47-0 | 3,10-dibromo-8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-007 | 193276-49-2 | (R)-3,10-dibromo-8-chloro-11-(piperidin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-008 | 157688-46-5 | 2-(1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid |
| LONA-009 | 193276-76-5 | tert-butyl (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxylate |
| LONA-010 | 193276-77-6 | (R)-1-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-(piperidin-4-yl)ethan-1-one |
| Code | CAS No. | Intermediate |
|---|---|---|
| LONA-006 | 193276-47-0 | 3,10-dibromo-8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-007 | 193276-49-2 | (R)-3,10-dibromo-8-chloro-11-(piperidin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| LONA-022 | 102096-25-3Available | 2,2,2-trifluoroethyl isobutyrate |
| LONA-023 | - | 1-(4-(3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)-2-methylpropan-1-one |
| LONA-024 | 193276-47-0 | 3,10-dibromo-8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
Frequently asked questions
What are the approved indications of Lonafarnib?
Approved indications include: 早衰综合征.
When does the Lonafarnib patent expire?
No public expiry year is available for Lonafarnib yet; this page updates once verified.
How many synthesis routes are recorded for Lonafarnib?
3 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Lonafarnib intermediates?
2 intermediate CAS of Lonafarnib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Lonafarnib intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29